Advertisement
Screener

BIOGEN INC. (BIIB) Share-based Payment Arrangement, Amount Capitalized

2.1 / 5 stars · 50/118 Roast Me

BIOGEN INC. Share-based Payment Arrangement, Amount Capitalized

BIOGEN INC. (BIIB) reported Share-based Payment Arrangement, Amount Capitalized of $3.80 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.

Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement

us-gaap:EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsCapitalizedAmount · last filed 2026-04-29

  • BIOGEN INC. share-based payment arrangement, amount capitalized for the quarter ending 2026-03-31 was $3.80M, a 22.58% increase year-over-year.
  • BIOGEN INC. share-based payment arrangement, amount capitalized for the quarter ending 2025-12-31 was $3.00M, a 30.43% increase year-over-year.
  • BIOGEN INC. share-based payment arrangement, amount capitalized for the quarter ending 2025-09-30 was $3.10M, a 29.17% increase year-over-year.
  • BIOGEN INC. share-based payment arrangement, amount capitalized for the quarter ending 2025-06-30 was $3.20M, a 39.13% increase year-over-year.
  • BIOGEN INC. share-based payment arrangement, amount capitalized for fiscal 2025 was $12.40M, a 20.39% increase from fiscal 2024.
  • BIOGEN INC. share-based payment arrangement, amount capitalized for fiscal 2024 was $10.30M, a 0.98% increase from fiscal 2023.
  • BIOGEN INC. share-based payment arrangement, amount capitalized for fiscal 2023 was $10.20M, a 9.68% increase from fiscal 2022.
  • BIOGEN INC. share-based payment arrangement, amount capitalized for fiscal 2022 was $9.30M, a 16.25% increase from fiscal 2021.
Period endShare-based Payment Arrangement, Amount Capitalized 3 monthShare-based Payment Arrangement, Amount Capitalized 3 month as first filedShare-based Payment Arrangement, Amount Capitalized 6 monthShare-based Payment Arrangement, Amount Capitalized 6 month as first filedShare-based Payment Arrangement, Amount Capitalized 9 monthShare-based Payment Arrangement, Amount Capitalized 9 month as first filedShare-based Payment Arrangement, Amount Capitalized 12 monthShare-based Payment Arrangement, Amount Capitalized 12 month as first filed
2026-03-31$3.80M
10-Q · filed 2026-04-29
$6.80M
derived: sum of 2 quarters · filed 2026-04-29
$9.90M
derived: sum of 3 quarters · filed 2026-04-29
$13.10M
derived: sum of 4 quarters · filed 2026-04-29
2025-12-31$3.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06
$6.10M
derived: sum of 2 quarters · filed 2026-02-06
$9.30M
derived: sum of 3 quarters · filed 2026-02-06
$12.40M
10-K · filed 2026-02-06
2025-09-30$3.10M
10-Q · filed 2025-10-30
$6.30M
derived: sum of 2 quarters · filed 2025-10-30
$9.40M
10-Q · filed 2025-10-30
$11.70M
derived: sum of 4 quarters · filed 2026-04-29
2025-06-30$3.20M
10-Q · filed 2025-07-31
$6.30M
10-Q · filed 2025-07-31
$8.60M
derived: sum of 3 quarters · filed 2026-04-29
$11.00M
derived: sum of 4 quarters · filed 2026-04-29
2025-03-31$3.10M
10-Q · filed 2026-04-29
$5.40M
derived: sum of 2 quarters · filed 2026-04-29
$7.80M
derived: sum of 3 quarters · filed 2026-04-29
$10.10M
derived: sum of 4 quarters · filed 2026-04-29
2024-12-31$2.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06
$4.70M
derived: sum of 2 quarters · filed 2026-02-06
$7.00M
derived: sum of 3 quarters · filed 2026-02-06
$10.30M
10-K · filed 2026-02-06
2024-09-30$2.40M
10-Q · filed 2025-10-30
$4.70M
derived: sum of 2 quarters · filed 2025-10-30
$8.00M
10-Q · filed 2025-10-30
$9.70M
derived: sum of 4 quarters · filed 2026-02-06
2024-06-30$2.30M
10-Q · filed 2025-07-31
$5.60M
10-Q · filed 2025-07-31
$7.30M
derived: sum of 3 quarters · filed 2026-02-06
$9.90M
derived: sum of 4 quarters · filed 2026-02-06
2024-03-31$3.30M
10-Q · filed 2025-05-01
$5.00M
derived: sum of 2 quarters · filed 2026-02-06
$7.60M
derived: sum of 3 quarters · filed 2026-02-06
$10.20M
derived: sum of 4 quarters · filed 2026-02-06
2023-12-31$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06
$4.30M
derived: sum of 2 quarters · filed 2026-02-06
$6.90M
derived: sum of 3 quarters · filed 2026-02-06
$10.20M
10-K · filed 2026-02-06
2023-09-30$2.60M
10-Q · filed 2024-10-30
$5.20M
derived: sum of 2 quarters · filed 2024-10-30
$8.50M
10-Q · filed 2024-10-30
$10.70M
derived: sum of 4 quarters · filed 2025-02-12
2023-06-30$2.60M
10-Q · filed 2024-08-01
$5.90M
10-Q · filed 2024-08-01
$8.10M
derived: sum of 3 quarters · filed 2025-02-12
$10.10M
derived: sum of 4 quarters · filed 2025-02-12
2023-03-31$3.30M
10-Q · filed 2024-04-24
$5.50M
derived: sum of 2 quarters · filed 2025-02-12
$7.50M
derived: sum of 3 quarters · filed 2025-02-12
$9.80M
derived: sum of 4 quarters · filed 2025-02-12
2022-12-31$2.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12
$4.20M
derived: sum of 2 quarters · filed 2025-02-12
$6.50M
derived: sum of 3 quarters · filed 2025-02-12
$9.30M
10-K · filed 2025-02-12
2022-09-30$2.00M
10-Q · filed 2023-11-08
$4.30M
derived: sum of 2 quarters · filed 2023-11-08
$7.10M
10-Q · filed 2023-11-08
$8.80M
derived: sum of 4 quarters · filed 2024-02-14
2022-06-30$2.30M
10-Q · filed 2023-07-25
$5.10M
10-Q · filed 2023-07-25
$6.80M
derived: sum of 3 quarters · filed 2024-02-14
$8.70M
derived: sum of 4 quarters · filed 2024-02-14
2022-03-31$2.80M
10-Q · filed 2023-04-25
$4.50M
derived: sum of 2 quarters · filed 2024-02-14
$6.40M
derived: sum of 3 quarters · filed 2024-02-14
$8.10M
derived: sum of 4 quarters · filed 2024-02-14
2021-12-31$1.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14
$3.60M
derived: sum of 2 quarters · filed 2024-02-14
$5.30M
derived: sum of 3 quarters · filed 2024-02-14
$8.00M
10-K · filed 2024-02-14
2021-09-30$1.90M
10-Q · filed 2022-10-25
$3.60M
derived: sum of 2 quarters · filed 2022-10-25
$6.30M
10-Q · filed 2022-10-25
$7.50M
derived: sum of 4 quarters · filed 2023-02-15
2021-06-30$1.70M
10-Q · filed 2022-07-20
$4.30M
10-Q · filed 2022-07-20
$5.60M
derived: sum of 3 quarters · filed 2023-02-15
$7.50M
derived: sum of 4 quarters · filed 2023-02-15
2021-03-31$2.60M
10-Q · filed 2022-05-03
$3.90M
derived: sum of 2 quarters · filed 2023-02-15
$5.80M
derived: sum of 3 quarters · filed 2023-02-15
$7.30M
derived: sum of 4 quarters · filed 2023-02-15
2020-12-31$1.30M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15
$3.20M
derived: sum of 2 quarters · filed 2023-02-15
$4.70M
derived: sum of 3 quarters · filed 2023-02-15
$6.20M
10-K · filed 2023-02-15
2020-09-30$1.90M
10-Q · filed 2021-10-20
$3.40M
derived: sum of 2 quarters · filed 2021-10-20
$4.90M
10-Q · filed 2021-10-20
$6.00M
derived: sum of 4 quarters · filed 2022-02-03
2020-06-30$1.50M
10-Q · filed 2021-07-22
$3.00M
10-Q · filed 2021-07-22
$4.10M
derived: sum of 3 quarters · filed 2022-02-03
$5.80M
derived: sum of 4 quarters · filed 2022-02-03
2020-03-31$1.50M
10-Q · filed 2021-04-22
$2.60M
derived: sum of 2 quarters · filed 2022-02-03
$4.30M
derived: sum of 3 quarters · filed 2022-02-03
$7.10M
derived: sum of 4 quarters · filed 2022-02-03
2019-12-31$1.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03
$2.80M
derived: sum of 2 quarters · filed 2022-02-03
$5.60M
derived: sum of 3 quarters · filed 2022-02-03
$8.90M
10-K · filed 2022-02-03
2019-09-30$1.70M
10-Q · filed 2020-10-21
$4.50M
derived: sum of 2 quarters · filed 2020-10-21
$7.80M
10-Q · filed 2020-10-21
$9.60M
derived: sum of 4 quarters · filed 2021-02-03
2019-06-30$2.80M
10-Q · filed 2020-07-22
$6.10M
10-Q · filed 2020-07-22
$7.90M
derived: sum of 3 quarters · filed 2021-02-03
$11.40M
derived: sum of 4 quarters · filed 2021-02-03
2019-03-31$3.30M
10-Q · filed 2020-04-23
$5.10M
derived: sum of 2 quarters · filed 2021-02-03
$8.60M
derived: sum of 3 quarters · filed 2021-02-03
$11.40M
derived: sum of 4 quarters · filed 2021-02-03
2018-12-31$1.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03
$5.30M
derived: sum of 2 quarters · filed 2021-02-03
$8.10M
derived: sum of 3 quarters · filed 2021-02-03
$11.50M
10-K · filed 2021-02-03
2018-09-30$3.50M
10-Q · filed 2019-10-22
$6.30M
derived: sum of 2 quarters · filed 2019-10-22
$9.70M
10-Q · filed 2019-10-22
$11.70M
derived: sum of 4 quarters · filed 2020-02-06
2018-06-30$2.80M
10-Q · filed 2019-07-24
$6.20M
10-Q · filed 2019-07-24
$8.20M
derived: sum of 3 quarters · filed 2020-02-06
$10.70M
derived: sum of 4 quarters · filed 2020-02-06
2018-03-31$3.40M
10-Q · filed 2019-04-24
$5.40M
derived: sum of 2 quarters · filed 2020-02-06
$7.90M
derived: sum of 3 quarters · filed 2020-02-06
$10.30M
derived: sum of 4 quarters · filed 2020-02-06
2017-12-31$2.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06
$4.50M
derived: sum of 2 quarters · filed 2020-02-06
$6.90M
derived: sum of 3 quarters · filed 2020-02-06
$9.60M
10-K · filed 2020-02-06
2017-09-30$2.50M
10-Q · filed 2018-10-23
$4.90M
derived: sum of 2 quarters · filed 2018-10-23
$7.60M
10-Q · filed 2018-10-23
$11.50M
derived: sum of 4 quarters · filed 2019-02-06
2017-06-30$2.40M
10-Q · filed 2018-07-24
$5.10M
10-Q · filed 2018-07-24
$9.00M
derived: sum of 3 quarters · filed 2019-02-06
$12.20M
derived: sum of 4 quarters · filed 2019-02-06
2017-03-31$2.70M
10-Q · filed 2018-04-24
$6.60M
derived: sum of 2 quarters · filed 2019-02-06
$9.80M
derived: sum of 3 quarters · filed 2019-02-06
$14.20M
derived: sum of 4 quarters · filed 2019-02-06
2016-12-31$3.90M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06
$7.10M
derived: sum of 2 quarters · filed 2019-02-06
$11.50M
derived: sum of 3 quarters · filed 2019-02-06
$14.60M
10-K · filed 2019-02-06
-$14.60M
10-K · filed 2017-02-02
2016-09-30$3.20M
10-Q · filed 2017-10-24
$7.60M
derived: sum of 2 quarters · filed 2017-10-24
$10.70M
10-Q · filed 2017-10-24
$13.30M
derived: sum of 4 quarters · filed 2018-02-01
2016-06-30$4.40M
10-Q · filed 2017-07-25
$7.50M
10-Q · filed 2017-07-25
$10.10M
derived: sum of 3 quarters · filed 2018-02-01
$12.90M
derived: sum of 4 quarters · filed 2018-02-01
2016-03-31$3.10M
10-Q · filed 2017-04-25
$5.70M
derived: sum of 2 quarters · filed 2018-02-01
$8.50M
derived: sum of 3 quarters · filed 2018-02-01
$10.70M
derived: sum of 4 quarters · filed 2018-02-01
2015-12-31$2.60M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01
$5.40M
derived: sum of 2 quarters · filed 2018-02-01
$7.60M
derived: sum of 3 quarters · filed 2018-02-01
$11.00M
10-K · filed 2018-02-01
-$11.00M
10-K · filed 2016-02-03
2015-09-30$2.80M
10-Q · filed 2016-10-26
$5.00M
derived: sum of 2 quarters · filed 2016-10-26
$8.40M
10-Q · filed 2016-10-26
-$9.10M
derived: sum of 4 quarters · filed 2017-02-02
2015-06-30$2.20M
10-Q · filed 2016-07-21
$5.60M
10-Q · filed 2016-07-21
-$11.90M
derived: sum of 3 quarters · filed 2017-02-02
-$9.60M
derived: sum of 4 quarters · filed 2017-02-02
2015-03-31$3.40M
10-Q · filed 2016-04-21
-$14.10M
derived: sum of 2 quarters · filed 2017-02-02
-$11.80M
derived: sum of 3 quarters · filed 2017-02-02
-$9.20M
derived: sum of 4 quarters · filed 2017-02-02
2014-12-31-$17.50M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02
-$15.20M
derived: sum of 2 quarters · filed 2017-02-02
-$12.60M
derived: sum of 3 quarters · filed 2017-02-02
-$10.00M
10-K · filed 2017-02-02
2014-09-30$2.30M
10-Q · filed 2015-10-21
$4.90M
derived: sum of 2 quarters · filed 2015-10-21
$7.50M
10-Q · filed 2015-10-21
-$9.70M
derived: sum of 4 quarters · filed 2016-02-03
2014-06-30$2.60M
10-Q · filed 2015-07-24
$5.20M
10-Q · filed 2015-07-24
-$12.00M
derived: sum of 3 quarters · filed 2016-02-03
-$9.60M
derived: sum of 4 quarters · filed 2016-02-03
2014-03-31$2.60M
10-Q · filed 2015-04-24
-$14.60M
derived: sum of 2 quarters · filed 2016-02-03
-$12.20M
derived: sum of 3 quarters · filed 2016-02-03
-$9.50M
derived: sum of 4 quarters · filed 2016-02-03
2013-12-31-$17.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03
-$14.80M
derived: sum of 2 quarters · filed 2016-02-03
-$12.10M
derived: sum of 3 quarters · filed 2016-02-03
-$9.80M
10-K · filed 2016-02-03
2013-09-30$2.40M
10-Q · filed 2014-10-22
-$2.40M
10-Q · filed 2013-10-28
$5.10M
derived: sum of 2 quarters · filed 2014-10-22
$7.40M
10-Q · filed 2014-10-22
-$7.40M
10-Q · filed 2013-10-28
$6.00M
derived: sum of 4 quarters · filed 2015-02-04
2013-06-30$2.70M
10-Q · filed 2014-07-23
-$2.70M
10-Q · filed 2013-07-25
$5.00M
10-Q · filed 2014-07-23
-$5.00M
10-Q · filed 2013-07-25
$3.60M
derived: sum of 3 quarters · filed 2015-02-04
$2.10M
derived: sum of 4 quarters · filed 2015-02-04
2013-03-31$2.30M
10-Q · filed 2014-04-23
-$2.30M
10-Q · filed 2013-04-25
$900.00K
derived: sum of 2 quarters · filed 2015-02-04
-$600.00K
derived: sum of 3 quarters · filed 2015-02-04
-$1.90M
derived: sum of 4 quarters · filed 2015-02-04
2012-12-31-$1.40M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04
-$2.90M
derived: sum of 2 quarters · filed 2015-02-04
-$4.20M
derived: sum of 3 quarters · filed 2015-02-04
-$5.40M
10-K · filed 2015-02-04
2012-09-30-$1.50M
10-Q · filed 2013-10-28
-$2.80M
derived: sum of 2 quarters · filed 2013-10-28
-$4.00M
10-Q · filed 2013-10-28
-$5.20M
derived: sum of 4 quarters · filed 2014-02-06
2012-06-30-$1.30M
10-Q · filed 2013-07-25
$1.30M
10-Q · filed 2012-07-24
-$2.50M
10-Q · filed 2013-07-25
$2.50M
10-Q · filed 2012-07-24
-$3.70M
derived: sum of 3 quarters · filed 2014-02-06
-$5.00M
derived: sum of 4 quarters · filed 2014-02-06
2012-03-31-$1.20M
10-Q · filed 2013-04-25
$1.20M
10-Q · filed 2012-05-01
-$2.40M
derived: sum of 2 quarters · filed 2014-02-06
-$3.70M
derived: sum of 3 quarters · filed 2014-02-06
-$2.70M
derived: sum of 4 quarters · filed 2014-02-06
2011-12-31-$1.20M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06
-$2.50M
derived: sum of 2 quarters · filed 2014-02-06
-$1.50M
derived: sum of 3 quarters · filed 2014-02-06
-$4.50M
10-K · filed 2014-02-06
$4.50M
10-K · filed 2012-02-03
2011-09-30-$1.30M
10-Q · filed 2012-10-25
-$300.00K
derived: sum of 2 quarters · filed 2012-10-25
-$3.30M
10-Q · filed 2012-10-25
-$300.00K
derived: sum of 4 quarters · filed 2013-02-05
2011-06-30$1.00M
10-Q · filed 2012-07-24
-$1.00M
10-Q · filed 2011-07-26
$2.00M
10-Q · filed 2012-07-24
-$2.00M
10-Q · filed 2011-07-26
$1.00M
derived: sum of 3 quarters · filed 2013-02-05
$100.00K
derived: sum of 4 quarters · filed 2013-02-05
2011-03-31$1.00M
10-Q · filed 2012-05-01
-$1.00M
10-Q · filed 2011-04-21
$0.00
derived: sum of 2 quarters · filed 2013-02-05
-$900.00K
derived: sum of 3 quarters · filed 2013-02-05
-$1.60M
derived: sum of 4 quarters · filed 2013-02-05
2010-12-31-$1.00M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-05
-$1.90M
derived: sum of 2 quarters · filed 2013-02-05
-$2.60M
derived: sum of 3 quarters · filed 2013-02-05
-$3.50M
10-K · filed 2013-02-05
2010-09-30-$900.00K
10-Q · filed 2011-10-28
-$1.60M
derived: sum of 2 quarters · filed 2011-10-28
-$2.50M
10-Q · filed 2011-10-28
$8.60M
derived: sum of 4 quarters · filed 2012-02-03
2010-06-30-$700.00K
10-Q · filed 2011-07-26
-$1.60M
10-Q · filed 2011-07-26
$9.50M
derived: sum of 3 quarters · filed 2012-02-03
$7.80M
derived: sum of 4 quarters · filed 2012-02-03
2010-03-31-$900.00K
10-Q · filed 2011-04-21
$10.20M
derived: sum of 2 quarters · filed 2012-02-03
$8.50M
derived: sum of 3 quarters · filed 2012-02-03
$7.10M
derived: sum of 4 quarters · filed 2012-02-03
2009-12-31$11.10M
derived: 10-K 12 month − 10-Q 9 month · filed 2012-02-03
$9.40M
derived: sum of 2 quarters · filed 2012-02-03
$8.00M
derived: sum of 3 quarters · filed 2012-02-03
$6.30M
10-K · filed 2012-02-03
-$6.30M
10-K · filed 2011-02-04
2009-09-30-$1.70M
10-Q · filed 2010-10-26
-$3.10M
derived: sum of 2 quarters · filed 2010-10-26
-$4.80M
10-Q · filed 2010-10-26
2009-06-30-$1.40M
10-Q · filed 2010-07-20
-$3.10M
10-Q · filed 2010-07-20
2008-12-31-$7.50M
10-K · filed 2011-02-04

Similar stocks

Stock NameCountryMarket CapPE Ratio
Revolution Medicines, Inc. (RVMD)United States$42.805B-22.69
EXELIXIS, INC. (EXEL)United States$14.358B16.15
NEUROCRINE BIOSCIENCES INC (NBIX)United States$14.131B24.25
HALOZYME THERAPEUTICS, INC. (HALO)United States$13.083B21.59
Twist Bioscience Corp (TWST)United States$11.540B-47.21
BIO-TECHNE Corp (TECH)United States$11.379B74.68
REPLIGEN CORP (RGEN)United States$10.755B185.31
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
ImmunityBio, Inc. (IBRX)United States$9.157B-9.29